Navigation Links
Web-Based Genomics Tool Designed to Help Predict Disease Susceptibility

A new gene information resource designed to aid biomedical researchers in more effectively identifying small alterations// in the human genome that are associated with individuals' susceptibility to disease has been established. Researchers at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati’s Computational Medicine Center developed polyDoms.

"PolyDoms is part of a new wave of informatic resources that we and others in the computational biology community are developing to expedite and advance research in personalized, predictive, and preventive medicine," says Bruce Aronow, Ph.D., co-director of the Center for Computational Medicine and professor of pediatrics at Cincinnati Children's and the University of Cincinnati.

PolyDoms offers researchers a single web-based tool that integrates diverse biomedical research information concerning genetic influences of disease with computational predictions of the impact of genomic changes on protein structures and functions. It has a user-friendly graphical and downloadable format that provides researchers with a list of genetic variations that they can analyze in their patient groups to gain more information regarding causes and susceptibility to disease.

"Having this computational tool available to researchers will help prioritize which genetic variations are most likely to alter the structure and function of a protein, and provides us with critical information related to disease susceptibility, progression, and targets for therapeutic interventions," states David A. Schwartz, M.D. director of the National Institute of Environmental Health Sciences (NIEHS), which funded the work along with the NCI.



Source: Bio-Bio Technology
SR
'"/>




Page: 1

Related medicine news :

1. Web-Based Training Programme For Africa Vets
2. International Conference On Malaria - Laveran To Genomics
3. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Nanocubes Designed For Delivering Cells
6. Human Body Designed To Resist Weight Loss
7. Special Footwear For Diabetics To Be Designed
8. A New Test Designed To Track Down Allergens
9. Snake Like Robots Designed to Assist Surgeons
10. Virus Level could Predict Cervical Cancer Risk
11. Long-Term Survival can be Predicted by a Simple Lung Test
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... Pass, OR (PRWEB) , ... April 29, 2016 , ... ... suggest dinner as the meal to miss. That was among the many new lifestyle ... Nutrition, on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and ...
(Date:4/29/2016)... ... , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. Mickey ... -- are proud of the recent release of their 2014 in vitro fertilization success ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows HRC/OC ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... adding BC and AD, saying it is time to set the record straight. Traditionally, ... says this simply cannot possibly be true and offers explanation. , “To start with, ...
(Date:4/28/2016)... ... April 29, 2016 , ... Sublime Beauty® is offering a special deal on its webstore. ... off. The discount is applied to the product with lesser value. In addition, a ... purchase $250 or more in products. , "So many women (men, too) love our products ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Oasmia Pharmaceutical ... of a new generation of drugs within human ... results for Paclical/Apealea in the Phase III study ... epithelial ovarian cancer. These preliminary results showed non-inferiority ... with carboplatin versus Taxol in combination with carboplatin. ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... 2016 US demand for infection prevention ... percent annually to $27.6 billion in 2020.  Increasing ... decrease rates of healthcare-associated infections (HAIs) will boost ... services.  Although declining, the overall rate of certain ... set by the CDC.  Recent statistics indicate that ...
Breaking Medicine Technology: